SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Share News (NFX)

Share Price Information for Nuformix (NFX)

Share Price is delayed by 15 minutes
Get Live Data
0.205    0.003 (1.49%)
Bid:
0.19
Ask:
0.22
Spread: 0.03 (15.789%)
Market Cap: £5.35m
NFX Live PriceLast checked at - London Stock Exchange

Intraday Nuformix Share Chart

Nuformix News

Nuformix inks cannabinoid therapeutics deal with Ebers Tech
9 Apr 2019

Nuformix inks cannabinoid therapeutics deal with Ebers Tech

(Sharecast News) - Pharmaceutical development company Nuformix has inked an agreement for cannabinoid therapeutics development, licensing and commerci...

WINNERS & LOSERS SUMMARY: 7digital Warns Of Need For Capital Raise
9 Apr 2019

WINNERS & LOSERS SUMMARY: 7digital Warns Of Need For Capital Raise

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNER...

Nuformix Doses First Patient In NXP001 Anti-Nausea Drug Trial
22 Mar 2019

Nuformix Doses First Patient In NXP001 Anti-Nausea Drug Trial

LONDON (Alliance News) - Nuformix PLC on Friday said it has begun clinical studies for its anti-nausea drug NXP001 and dosed its first patient.Shares ...

MHRA gives go-ahead to Nuformix for human studies
27 Feb 2019

MHRA gives go-ahead to Nuformix for human studies

(Sharecast News) - Pharmaceutical development company Nuformix has received approval from the UK Medicines and Healthcare Products Regulatory Agency (...

Nuformix Reports Positive Results From NXP002 Pre-Clinical Trial
3 Dec 2018

Nuformix Reports Positive Results From NXP002 Pre-Clinical Trial

LONDON (Alliance News) - Pharmaceutical development firm Nuformix PLC on Monday reported positive results from its completed NXP002 fibrosis programme...

Nuformix Expands NXP001 Agreement With Additional Pre-Clinical Study
27 Nov 2018

Nuformix Expands NXP001 Agreement With Additional Pre-Clinical Study

LONDON (Alliance News) - Pharmaceutical development firm Nuformix PLC said on Tuesday it has expanded its current licensing agreement with partner New...

Nuformix Rises As NXP001 Passes "Major" Pre-Clinical Milestone
14 Sep 2018

Nuformix Rises As NXP001 Passes "Major" Pre-Clinical Milestone

LONDON (Alliance News) - Shares in pharmaceutical firm Nuformix PLC rose Friday it has received a GBP500,000 payment after its NXP001 product reached ...

UK Shareholder Meetings Calendar - Next 7 Days
12 Sep 2018

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 13 SeptemberBahamas PetroleumFlybe GroupBetter Capital PCCWorldwide 14 UK 17